HILARY HARLESS: Open Payments
NPI 1700402021 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 76 payments from 13 companies in 2025. Trend: 2023 $129 · 2024 $33 · 2025 $1,425
Food & beverage: $1,325Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $424 |
| SK Life Science, Inc. | 6 | $171 |
| Janssen Biotech, Inc. | 4 | $167 |
| Eisai Inc. | 5 | $139 |
| Lundbeck LLC | 5 | $103 |
| ACADIA Pharmaceuticals Inc | 5 | $99 |
| Lilly USA, LLC | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
Products named: UBRELVY, QULIPTA, Leqembi, VYALEV, NUPLAZID, VYEPTI, AMYVID, AUSTEDO XR.
Industry payments across AL — which companies pay providers there.
